Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Immunohistochemistry Stories

2011-11-29 07:12:00

IRVINE, Calif., Nov. 29, 2011 /PRNewswire/ -- GeneTex, a leading manufacturer of antibodies and antibody-related reagents, is pleased to announce that they will be launching a new line of antibodies against Hice1 and Hec1. Both of these targets are key players in spindle assembly. (Photo: http://photos.prnewswire.com/prnh/20111129/LA13485-a) (Logo: http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b) Hice1 is a novel microtubule-associated protein that is required for the...

2011-10-06 14:52:00

BRANFORD, Conn., Oct. 6, 2011 /PRNewswire/ -- HistoRx, the leader in quantitative immunohistochemistry, advances its proprietary position in digital pathology through the recent issuance of US patents covering key features necessary for achievement of reproducible, standardized image analysis results. The U.S. Patent and Trademark Office has granted two new patents protecting the company's methods for standardization of digital microscopy instruments, methods required to generate...

2011-10-04 12:00:00

TUCSON, Ariz., Oct. 4, 2011 /PRNewswire/ -- The VENTANA anti-Helicobacter pylori (SP48) Rabbit Monoclonal Primary Antibody (H. pylori) is the first H. pylori antibody to receive 510(k) clearance from the Food and Drug Administration (FDA). Developed by Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, the VENTANA H. pylori antibody, when used in immunohistochemical (IHC) staining, aids in the detection of Helicobacter pylori, a bacterium linked to chronic gastritis,...

2011-10-03 19:39:58

Researchers have determined that a combination of P16 immunohistochemistry and DNA qPCR to test for viral E6 can accurately determine the oropharyngeal squamous cell carcinoma, a form of head and neck cancer, which derive from HPV16, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This has immediate clinical applications as we consider recruitment to clinical trials designed to de-escalate the intensity of therapy...

2011-09-12 13:32:00

TUCSON, Ariz., Sept. 12, 2011 /PRNewswire/ -- University Medical Center in Tucson (UMC) is validating the VENTANA INFORM HER2 Dual ISH DNA Probe cocktail assay (HER2 Dual ISH) on the BenchMark XT automated slide staining instrument to help determine HER2 gene status in breast cancer patients in an effort to change the paradigm for targeted treatment therapies. The assay, developed by Ventana Medical Systems, Inc. (Ventana), a member of the Roche group, is the first fully automated assay...

2011-08-23 11:00:00

IRVINE, Calif., Aug. 23, 2011 /PRNewswire/ -- GeneTex, a leading manufacturer of high quality antibodies, has launched several new specials on products from their large catalog containing more than 40,000 primary and secondary antibodies, DNA damage antibodies, proteins, peptides, and research reagents. Plus, GeneTex is introducing over 15,000 ELISA kits for quantitative measurements of proteins including cytokines, interleukins, growth factors, hormones, coagulation factors, and targets...

2011-08-02 07:00:00

TUCSON, Ariz., Aug. 2, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the launch of BenchMark ULTRA with new Ultimate Reagent Access (URA). BenchMark ULTRA with URA is the world's first platform that allows laboratories to process individual immunohistochemistry (IHC) and in situ hybridization (ISH) samples as soon as they arrive in the lab. This enhancement allows labs to quickly respond to unpredictable changes in workflow,...

2011-07-26 07:00:00

TUCSON, Ariz., July 26, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the launch of their OptiView DAB IHC Detection Kit, the first fully-automated immunohistochemistry (IHC) detection kit that combines both sensitive chemistry and flexible software to deliver highly customizable staining. OptiView Detection significantly enhances stain quality, allowing pathologists to view IHC assays more clearly than ever before. (Photo:...

2011-06-28 10:56:00

IRVINE, Calif., June 28, 2011 /PRNewswire/ -- GeneTex, a leading manufacturer of high quality antibodies, is pleased to announce that they will be launching a full line of zebrafish antibodies. Zebrafish have been increasingly utilized as a model organism for scientific research. Due to their short lifecycles and relatively large clutch sizes, they are a useful model for genetic studies. Zebrafish eggs are externally fertilized; therefore, researchers can control and manipulate the...

2011-06-14 17:56:00

TUCSON, Ariz., June 14, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today that the FDA approved the INFORM HER2 Dual ISH DNA Probe cocktail assay (HER2 Dual ISH) for commercialization in the United States. This is the first fully automated assay approved by the FDA for determination of HER2 gene status in breast cancer as an aid in the assessment of patients considered for treatment with Herceptin (trastuzumab). For breast cancer...